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Summary 
Precision global health is an approach similar to precision medicine, 
which facilitates, through innovation and technology, better targeting 
of public health interventions on a global scale, for the purpose of max-
imising their effectiveness and relevance. Illustrative examples in-
clude: the use of remote sensing data to fight vector-borne diseases; 
large databases of genomic sequences of foodborne pathogens help-
ing to identify origins of outbreaks; social networks and internet 
search engines for tracking communicable diseases; cell phone data in 
humanitarian actions; drones to deliver healthcare services in remote 
and secluded areas. Open science and data sharing platforms are pro-
posed for fostering international research programmes under fair, eth-
ical and respectful conditions. Innovative education, such as massive 
open online courses or serious games, can promote wider access to 
training in public health and improving health literacy. The world is 
moving towards learning healthcare systems. Professionals are 
equipped with data collection and decision support devices. They 
share information, which are complemented by external sources, and 
analysed in real time using machine learning techniques. They allow 
for the early detection of anomalies, and eventually guide appropriate 
public health interventions. This article shows how information-driven 
approaches, enabled by digital technologies, can help improving global 
health with greater equity. 
Key words: global health precision medicine; data science machine 
learning; open science; emerging infectious diseases; noncommunica-
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Introduction 
In a recent paper, we proposed a definition for global health based on 
six principles [1]:  
1. Global health addresses cross-border and multilevel health issues.  
2. It is “trans-disciplinary”, i.e., it mobilises all relevant academic dis-
ciplines and also nonacademic sectors of society.  
3. It studies complex systems in the real world. This complexity re-
quires trans-disciplinary system thinking to help find solutions.  
4. It seeks to provide affordable, effective and integrated innovation. 
This article demonstrates how affordable innovations are key in pre-
cision global health.  
5. It seeks health for all in a sustainable world. It is no longer possible 
to develop health care facilities, devices and services without a deep 
commitment and respect for our planet.  
6. Global health is committed to the normative framework of human 
rights and equity. This is an essential aspect of global health; be-
cause health is considered a human right, access to affordable health 
care matters greatly. 
Khoury et al. [2] discussed the sine qua non role of public health in the 
era of precision medicine, extending the discussion to tools beyond ge-
netics, such as health information technology. The authors expressed 
their concerns about the “disproportionate emphasis on genes, drugs, 
and disease, while neglecting strategies to address social determinants 
of health”. The authors defined “precision public health” as “providing 
the right intervention to the right population at the right time”, and 
stressed the need of more accurate methods for measurement. Khoury 
et al. emphasised the need, in the era of precision medicine, to shift the 
focus from treatment to prevention. Of note, precision public health 
would involve improving early detection of pathogens and infectious 
disease outbreaks (e.g., CDC Advanced Molecular Detection Infectious 
Disease Initiative). The authors discussed priorities for public health in 
the era of precision medicine: to make best use of the interconnectivity 
of digital data, adding molecular markers in registries, and to include 
and integrate disparate sources of data. 
More than 36 million people die annually from noncommunicable dis-
eases (NCDs) (63% of global deaths), including 14 million people who 
die too young, before the age of 70 years. More than 90% of these prem-
ature deaths from NCDs occur in low- and middle-income countries, 
and are largely preventable. Most premature deaths are linked to com-
mon risk factors, namely tobacco use, unhealthy diet, physical inactiv-
ity and harmful use of alcohol [3] Preventable deaths could effectively 
be the target of precision global health. In high-income countries, seven 
in every ten deaths are of people aged 70 years and older. People pre-
dominantly die of chronic diseases: cardiovascular diseases, cancers, 
dementia, chronic obstructive lung disease or diabetes. Lower respira-
tory infections remain the only leading infectious cause of death. Only 
1 in every 100 deaths involve children under 15 years of age. In low-
income countries, nearly four in every ten deaths are of children under 
15 years, and only two in every ten deaths are of people aged 70 years 
and older. People predominantly die of infectious diseases: lower res-
piratory infections, human immunodeficiency virus / acquired immu-
nodeficiency syndrome (HIV/AIDS), diarrhoeal diseases, malaria and 
tuberculosis collectively account for almost one third of all deaths in 
these countries. Complications of childbirth due to prematurity, birth 
 asphyxia and birth trauma are among the leading causes of death, claim-
ing the lives of many newborns and infants. 
Precision medicine, part of the larger movement of personalised medi-
cine, aims to target healthcare better with new technologies, often the 
so-called “-omics”, in order to be more effective. Personalised medicine 
is not romantic nostalgia for past medicine, when family physicians 
knew and provided care to each generation with an individual and hu-
man approach. Personalised medicine is closer to a mass customisation 
approach, as pioneered by companies like IKEA. It is not handicraft 
medical practice, but rather a mass customisation delivery of health 
care. Knowledge of the genomic sequence of a tumour may inform se-
lection of a drug or treatment with much higher probability of success 
than a treatment chosen without taking advantage of this information. 
In analogy to precision medicine, precision global health aims to pro-
pose appropriate, targeted interventions in global public health, thanks 
to innovation, in order to greatly improve efficacy. Innovations can be 
technological, providing they comply with the definition of global 
health in term of ethics, affordability and sustainability. Nontechnolog-
ical “soft” innovation is also crucial to driving global health interven-
tion with greater precision. 
Below, we describe a few examples drawn from the literature, without 
being exhaustive. 
Using remote sensing data to better fight vector-
borne diseases 
Satellites gather large amounts of data each day and with differing types 
of measurement. These can be combined and used for developing pre-
dictive models for the spread of vector-borne diseases. For example, 
correlations have been shown between the risk of West Nile virus trans-
mission and changes in the timing of the spring bloom, temperature var-
iability and moisture availability, all observed by satellites over the 
Great Plains of the US [4]. Various kinds of indicators can be obtained 
through remote sensing and inform on habitats and transmission risks 
of mosquitoes, ticks, black flies, tsetse flies, and sand-flies [5]. Improv-
ing spatial resolution enables the assessment of risks at the neighbour-
hood level, for example for Chikungunya transmission in Buenos Aires 
[6]. In countries where disease surveillance is scarce or failing, the use 
of remote sensing data to predict a high risk of emerging vector-borne 
diseases allows preventive measures, such as vector control in affected 
areas, to be fostered and targeted. By avoiding sprinkling and dispersion 
of resources, precision global health contributes to better targeting of 
development aid to where it is needed. It also helps to prioritise preven-
tion of outbreaks of emerging infectious diseases, which are much 
harder to control after they have started. 
Genomics to help targeting public health surveil-
lance 
The “Spanish cucumber crisis” was an outbreak of foodborne illness 
due to a novel strain of Escherichia coli O104:H4, which occurred in 
Germany in May and June 2011. It was severe enough to cause 53 
deaths, with 800 patients suffering from haemolytic uraemic syndrome, 
and affected about 4000 people [7]. Standard methods of investigation 
misled health authorities, which wrongly linked the bacteria to cucum-
bers imported from Spain. Later, at the end of June, the European Cen-
tre for Disease Control eventually established the link between the bac-
teria and contaminated seeds of soy bean sprouts imported from Egypt. 
Had the recently created 100K Foodborne Pathogen Genome Project 
[8] existed at that time, it would have been possible to quickly compare 
the genome of the culprit bacteria and existing sequences stored in the 
database. This would have saved precious time and lives. It would also 
have saved money, since the outbreak cost innocent Spanish exporters 
an estimated US$ 200 million/week. Precision global health not only 
helps saving lives, but has also an important economic impact. 
Data sharing platforms 
Health information systems everywhere, but especially in low income 
countries (LICs), are often disconnected from systems which require 
the data to inform policies on disease treatment and interventions. The 
data might exist, and this deficit does not usually derive from a lack of 
research or even published clinical trials. But the data are siloed or not 
interoperable. Precision medicine, personal or global, requires large da-
tasets to be effective. It is crucial to be able to federate databases in 
order to provide a body of evidence sufficiently consistent to guide pol-
icy. Individual patient data from many trials have been curated to enable 
interoperability and merged to allow consistent meta-analyses of this 
much-larger data set. In this way, assembling valuable research data 
from multiple studies could produce evidence that sparse data in single 
studies cannot achieve. For LICs notably, the WorldWide Antimalarial 
Resistance Network (WWARN) [9] is a partnership comprised of more 
than 260 collaborating institutes around the world. WWARN currently 
securely hosts more than 350 clinical trial data sets, comprising over 
135 000 patient records which have been harmonised. For instance, 
pooled analyses of artesunate-amodiaquine data (a recommended treat-
ment for uncomplicated Plasmodium falciparum malaria) show that 
providing the artemisinin and amodiaquine as a fixed combination 
preparation was more effective than treating people with two separate 
pills with slightly different dosage [10]. Children treated with another 
antimalarial treatment, dihydroartemisinin-piperaquine, were receiving 
a lower amount of the drug than expected by the drug developers, and 
these children were much more likely to fail treatment [11]; this evi-
dence supported changes to the WHO’s Guidelines for the treatment of 
malaria [12]. 
Merging data from many separate studies would require changes to the 
traditional path that has been followed for many decades. In addition to 
publishing each study separately in scientific journals, data sets would 
need to be shared and analysed collaboratively. This new approach will 
require the development of fair and responsible data sharing platforms. 
These platforms would need to assure that patients’ information is se-
curely stored and their privacy protected. The Global Alliance for Ge-
nomics and Health (GA4GH) is such an initiative [13]. 
Overall, sharing data from many different trials and producing analyses 
relevant for common regional actions will be a fundamental require-
ment for precision public health. 
Without this approach, simple accretion of individual studies will not 
move LICs forward to conquer neglected tropical diseases (NTDs) or 
emerging infections; collaborative analysis of data from multiple 
sources or studies can. 
Cell phone data to better target humanitarian action 
In many LICs the use of the cell phone for health interventions is far 
more developed and creative than in other parts of the world. This is 
particularly true for sub-Saharan Africa, which leapfrogged from a 
stage of no telephone or road networks to an increasingly digital econ-
omy based on smartphones. When Ebola hit West Africa in 2014, Mé-
decins Sans Frontières (MSF) and other nongovernmental organisations 
(NGOs) and health authorities took advantage of cell phone data to bet-
ter foresee the extension of the epidemic, and also to better target needs 
of the affected populations [14]. Similarly, outbreaks of cholera have 
been identified in rural Kenya by identifying abnormally slow move-
ments of customers equipped with cell phones, which could be due ei-
ther to sickness of people or to flooding (which usually occur two weeks 
before such outbreaks) [15]. Relationships between travellers and 
spread of malaria has been studied extensively in Senegal from call rec-
ord metadata, and provided recommendations to health authorities [16]. 
Influenza: can Google search terms be used as early 
warning signals? 
Seasonal influenza represents a huge burden each year, both in terms of 
health consequences, with excess hospitalisation and mortality ob-
served in the elderly, and in terms of economic impact, with sick leaves 
and increased use of the healthcare system. Although accurate predic-
tion of influenza epidemics would be useful for better planning and con-
trolling these seasonal outbreaks and their impact, this exercise is 
highly difficult, because of the complexity of the phenomenon and cha-
otic nature of the signal. Predictions of up to 3 weeks have proved reli-
able [17], but classic public health surveillance often reports data with 
a delay of a few weeks, limiting the potential for early intervention. An 
appropriate selection of Google, Twitter or Wikipedia could be a proxy 
for real-time measures for influenza epidemics [18–22]. Google Flu 
Trends, based on Google search terms, was highly promising. It pro-
vided an early warning signal for seasonal influenza, specifying when 
 it started and thus allowing latecomers into the vaccination scheme. At 
every seasonal outbreak, and particularly when influenza activity is in-
tense, general practices, hospital emergency services, and pharmacies 
are congested during the period of peak incidence. Better planning and 
forecasting may help with managing these resources. However, in Jan-
uary 2013, Google Flu Trends wrongly predicted a large outbreak of 
influenza in New York City, prompting Mayor Bloomberg to declare a 
state of emergency for the City. Pharmacies and emergency depart-
ments were stormed, the general panic was further amplified by the me-
dia, which in a vicious circle led to ever more searches on the Internet. 
Google Flu Trends signal was more and more worrying. A couple of 
weeks later, the US CDC reported no particular alarming epidemiolog-
ical situation in New York, which was similar to the rest of the country, 
and displayed the normal and expected pattern of a seasonal influenza 
outbreak. Google Flu Trends was then taunted and discredited by the 
press and the public health community [23]. Google decided to close its 
open access website, and now provides its controversial data only to a 
selection of universities for research purposes. We can see this story as 
teething problems linked to the rather small time series. It further high-
lights the fact that algorithms on a nontraditional data source used for 
epidemiological assessment need to be constantly updated. With time 
and the accumulation of longer and deeper experience, these troubles 
could be solved. Additional sources of information, such as Twitter [24] 
or Wikipedia [19, 25], or data from shopping (supermarket loyalty 
cards, pharmacy sales) should prove able to forecast influenza activity 
also, and could overcome the lack of accuracy provided by a single 
source. Health authorities will probably not give up traditional public 
health surveillance for these new practices, but could use them both. 
Drones to improve healthcare in developing coun-
tries 
Drones are an interesting example of synergies in technological sectors 
within and outside the health system. As smartphones are solving the 
communication needs in low-and middle-income countries, drone de-
liveries might solve transportation needs in countries where the road 
networks are wanting. Drones could deliver essential medicines, blood 
products, vaccines and diagnostic tests to remote parts, where tradi-
tional land-based transportation is not available or reliable. Many ob-
stacles to drone use exist: regulatory issues about the use of drones to 
deliver goods; skills and infrastructures needed to maintain and operate 
such equipment; appropriate and effective coordination between those 
shipping and those receiving services and products; appropriate pack-
ing to maintain product quality. There are, however, currently a few 
experiments where drones are being tested for medical supply delivery 
in various areas of the globe [26, 27], and it may be that drones will 
prove cost-effective. 
Massive open online scale for training health profes-
sionals 
The digital revolution allows for innovative methods in domains where 
global health diplomacy is struggling. The International Health Regu-
lations (IHR) is an international agreement, which was signed in 2005, 
between all the members of the WHO, binding 196 countries. It has 
been acknowledged that IHR is a powerful instrument for preventing 
diseases from becoming major threats at an international level, but the 
WHO and other key stakeholders failed to respond appropriately and in 
due time for many crises, namely the 2009 influenza H1N1 pandemic, 
the Ebola outbreak in West Africa, or Zika in Latin America. The IHR 
has has not been accused of this failure, but its implementation seemed 
inadequate. In many countries, national focal points (i.e., the teams in 
charge of implementing IHR) are not trained or evaluated, and local 
capacities in term of diagnostic or healthcare supplies are often lacking. 
To train these teams, a consortium of European universities led by the 
University of Geneva (Flahault A, personal communication) has pro-
posed as a pilot project to the WHO, an internet-based platform which 
simulates health crises through serious games. Serious games had not 
been used in global health until then. Participants “play” various roles 
involved in such a crisis (e.g., representatives from various ministries, 
and various countries, representatives from the WHO), and they are im-
mersed into a health crisis which is fictive but looks highly realistic. 
They have to take rapid decisions, in an atmosphere which mimics the 
one met in such outbreaks. These decisions may influence the course of 
the outbreak or the health crisis, and the system assesses in real time if 
answers, reactions and decisions are timely and if they fit IHR. Through 
better training of officials in charge, we improve readiness and raise the 
level of coordination. 
Towards a learning healthcare system 
A learning healthcare system applies the best known evidence, encour-
ages continuous learning, and allows for knowledge generation as a nat-
ural by-product of patient care delivery. It aims at creating a virtuous 
cycle of research and practice, using methods such as systems thinking, 
translation and patient empowerment [28]. 
Health informatics is the enabler of such a system, connecting personal, 
provider and population health information and providing feedback 
loops at many levels, thus creating computer-supported mechanisms for 
learning and for improving the quality of the overall health system. 
Think of a scenario where care professionals are equipped with data 
collection and decision-support devices used during patient care. These 
devices can share some information with public health information sys-
tems, which are then complemented by external sources (satellite im-
aging, air quality measurements, news feeds, disease models, etc.), in 
order to identify and locate abnormal situations that would necessitate 
a specific public health intervention. And imagine that these systems 
are also connected to personal mobile devices that can forward person-
alised messages to their owners, and can also inform the system with 
user-generated data and observations. This data ecosystem can be fur-
ther enriched by social media, internet-based sources, genome sequenc-
ing, sensors, etc., thus providing additional context, dimensions, and 
granularity to be exploited by big-data analytical engines and artificial 
intelligence algorithms. This could lead to new ways to forecast, simu-
late, recommend, deploy, and evaluate individual or population-wide 
precision health interventions. 
Most of the building blocks of this scenario do exist, but are insuffi-
ciently connected, because of many weak links: 
–  Integration requires unprecedented levels of semantic interoperabil-
ity and standardization 
–  Implementation faces many technical and organizational chal-
lenges, and raises unsolved ethical, legal and societal issues 
–  Impact on health outcomes is difficult to measure, and has been 
poorly addressed so far 
Further research should aim at strengthening these links through the de-
velopment of robust health information science tools, through the ad-
vancement of integration and implementation sciences, and through the 
elaboration of innovative evaluation methods to demonstrate impact on 
the health of populations. 
Machine learning: making sense of big data 
Many of the future innovations in health care and public health will be 
rooted in our ability to collect very large data sets at unparalleled levels, 
both in scale and in scope. But data alone has no value per se – it needs 
to be mined, analysed, and interpreted correctly to unlock its innovative 
potential. Thankfully, our capability of analysing large datasets has kept 
pace with the capabilities of collecting the data. Advances in machine 
learning, and in deep learning in particular, allow us to analyse big data 
in efficient ways. Deep learning is now at a stage where it allows for 
pattern recognition close to, or at, human accuracy, something deemed 
impossible just a decade ago. Importantly, deep learning is a form of 
end-to-end machine learning, and does not require the extreme levels 
of domain expertise that made traditional attempts at pattern recogni-
tion very challenging [29]. 
We think that such deep learning models will be quite important for 
precision global health. Two domains with many applications for health 
are image recognition and text interpretation, which are relevant in a 
number of settings from correctly interpreting text documents such as 
health records or social media messages to interpreting medical images. 
These two areas have seen tremendous advances in the past few years 
(with error rates on benchmark classifications such as ImageNet drop-
ping from mid-two-digit levels to low one-digit levels in less than five 
years [30]. Deep learning algorithms will not only help us make sense 
of large datasets, but can then also easily be implemented on 
 smartphones, with the potential to create a virtuous cycle of increased 
data collection and improved algorithms. 
Conclusion 
Timely and accurate health-related data are a critical resource to moni-
tor, assess and guide public health interventions. The potential of “big 
data” to transform medicine and raise expectations for precision medi-
cine has driven substantial investments that have improved data collec-
tion and analyses. Major progress has been made in recent decades: 
tools to improve health information systems, including electronic med-
ical records, capacity for transmission of standardised surveillance data, 
and sophisticated data sharing platforms for genomic information. Yet, 
the benefits of this progress have accrued almost exclusively to well-
resourced regions. 
In LICs, the weakness of the health information systems, in terms of 
accuracy, data quality and access to real time information has slowed 
down progress in public health. As a result, data sharing between data 
collectors and policy makers has been minimal, seriously diminishing 
the utility of the data that are collected. In 2015, the World Health Or-
ganization, the United States Agency for International Development, 
and the World Bank published “The Roadmap for Measurement and 
Accountability” [31]. The roadmap was a call for action to improve data 
collection, analysis, access and use. The objectives are very ambitious 
and will require multiple levels of coordination, resources and political 
will; all of these will take time to assemble. 
Medical interventions and policies have also been adapted and im-
proved in the last decades with a focus on LICs. Despite these improve-
ments, there is limited evidence for interventions focused on particu-
larly vulnerable subpopulations such as malnourished children, preg-
nant women and patients affected by neglected tropical diseases. Thus, 
many segments of society in LICs still have the poorest health out-
comes. While the demand in rich countries has focused on individual 
medical interventions, the needs of LICs require broader public health 
responses; in other words, a precision public health response is needed, 
prior to individual precision medicine. 
Lessons learned and tools developed by well-resourced countries can 
surely benefit LICs. But how? Resource-poor countries can develop 
adapted innovative tools to improve their health information systems, 
including data collection tools, data transmission systems and use of 
international data standards. These adaptations must also address data 
security issues and fair systems and governance policy for data sharing 
and use. In rural LICs, high-speed internet access is still the exception 
and, in many areas, even mobile telephone technology will not support 
these modern systems in the near future. Improving and adapting health 
information system tools and solving these technical constraints are 
both urgent needs, and these cannot depend solely on commercially 
driven technology. Precision global health approaches could guide and 
mobilise the optimal use of resources, for both preventive and therapeu-
tic interventions. 
Taking advantage of affordable and sustainable innovations to foster 
progress and improvement in global health is something we can name 
“precision global health”. We need to provide better access to those in-
novations that bring better and longer health to populations. We need 
to propose solutions for global health issues such as outbreaks of 
emerging infectious diseases, or mental health problems, or noncom-
municable diseases, or smoking tobacco, or climate-change related 
health troubles. For all these complex and cross-border issues, there are 
examples, mostly success stories, where affordable and sustainable in-
novations help to bring solutions. Precision global health will contrib-
ute to greater effectiveness of intervention measures in global public 
health, by relying on cutting-edge innovations. 
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